An open-label, multicenter, study of INC424 monotherapy or in combination with azacitidine for patients with post-myeloproliferative disorders (MPD) – AML or with CMML

Update Il y a 4 ans
Reference: DRKS00007802

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Inclusion criteria

  • C92.0 - Acute myeloblastic leukaemia [AML],C93.1 - Chronic myelomonocytic leukaemia

Links